Cargando…
Bile acid indices as biomarkers for liver diseases I: Diagnostic markers
BACKGROUND: Hepatobiliary diseases result in the accumulation of toxic bile acids (BA) in the liver, blood, and other tissues which may contribute to an unfavorable prognosis. AIM: To discover and validate diagnostic biomarkers of cholestatic liver diseases based on the urinary BA profile. METHODS:...
Autores principales: | Alamoudi, Jawaher Abdullah, Li, Wenkuan, Gautam, Nagsen, Olivera, Marco, Meza, Jane, Mukherjee, Sandeep, Alnouti, Yazen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080550/ https://www.ncbi.nlm.nih.gov/pubmed/33959226 http://dx.doi.org/10.4254/wjh.v13.i4.433 |
Ejemplares similares
-
Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model
por: Alamoudi, Jawaher Abdullah, et al.
Publicado: (2021) -
Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases
por: Li, Wenkuan, et al.
Publicado: (2022) -
ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018) -
The Synergistic Effect of an ATP-Competitive Inhibitor of mTOR and Metformin on Pancreatic Tumor Growth
por: Soliman, Ghada A, et al.
Publicado: (2020) -
Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet
por: Lu, Hong, et al.
Publicado: (2022)